#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pemphigus Fms-like tyrosine kinase 3 positive Glomerulonephritis chronic Infertility male Insulinoma Medullary thyroid cancer Precursor T-lymphoblastic lymphoma/leukaemia recurrent Endometrial cancer VEXAS syndrome Mantle cell lymphoma stage II Piriformis syndrome Acute graft versus host disease in intestine Measles Acute respiratory distress syndrome Rhabdoid tumour More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Treatment Friedreich’s ataxia – Trials in Disease Undifferentiated sarcoma – Trials in Disease Waldenstrom’s macroglobulinaemia – Diagnostics Pulmonary sarcoidosis Rett syndrome – Treatment Prolymphocytic leukaemia – Treatment Stevens-Johnson syndrome – Trials in Disease Congenital nephrogenic diabetes insipidus – Life with Disease VEXAS syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexrazoxane Hydrochloride Methyl Aminolevulinate Botaretigene Sparoparvovec Sultiame Vafidemstat Omaveloxolone VERT-002 CANNABINOL Ganirelix Deupirfenidone Leniolisib Phosphate Nilutamide Darunavir Glenzocimab Doconexent Pariglasgene Brecaparvovec Immunglobulin Chlorpromazine GSK5784283 Hydroxi-Methionine Calcium More therapies…

    Learn about Your Condition

    Embolic stroke Metabolic syndrome Acquired ATTR amyloidosis Atopic keratoconjunctivitis Epicondylitis Systemic mastocytosis Atrial septal defect Hyperoxaluria Antisynthetase syndrome Mumps Pleomorphic leiomyosarcoma Compulsive sexual behaviour Partial lipodystrophy Periodontitis Osteopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Study on Carvedilol for Preventing Complications in Patients with Early-Stage Cirrhosis and High Blood Pressure in the Liver

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cirrhosis alcoholic
    Investigated Drugs:
    • Carvedilol
    France

  • Long-term safety and effectiveness study of atacicept in patients with IgA nephropathy (IgAN)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Atacicept
    Belgium Czechia Germany Greece Poland Spain

  • Study on the Effects of Intraperitoneal Furosemide in Patients with Heart Failure on Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Spain

  • Study on Prednisolone for Treating Acute Interstitial Nephritis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tubulointerstitial nephritis
    Investigated Drugs:
    • Prednisolone
    Denmark

  • Study on Pembrolizumab for Patients with High-Risk Melanoma Without Signs of Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Pembrolizumab
    Belgium

  • Study on the Effect of Human Serum Albumin in Critically Ill Patients with Septic Shock at High Risk of Acute Kidney Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    • Acute kidney injury
    Investigated Drugs:
    • Human Serum Albumin
    Spain
Previous Page
1 … 3 4 5 6 7 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!